维普期刊资源整合服务平台（V6.5）

222篇 您的检索式：作者名="Okusaka"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	胆道肿瘤临床实践指南(英文第三版)显示文摘日本肝胆胰外科学会(JSHBPS)于2007年出版第一版胆道肿瘤(胆管癌、胆囊癌及壶腹癌)临床实践指南,于2014年更新第二版,2021年英文第三版胆道肿瘤临床实践指南围绕6个主题提出若干临床问题,基于相关循证医学证据并组织专家讨论后,最终确定推荐意见、推荐强度以及推荐说明。根据证据推荐分级的评估、制订与评价(GRADE)系统,推荐强度被分为1级(强)或者2级(弱)。英文第三版胆道肿瘤临床实践指南中提出的31个临床问题涵盖:(1)预防性治疗;(2)诊断;(3)胆道引流;(4)外科治疗;(5)化疗;(6)放疗。31个临床问题中,14个问题给予推荐强度为强的推荐意见,14个问题给予推荐强度为弱的推荐意见,剩余的3个问题未给予推荐意见。每条推荐意见都进行推荐强度说明。最新版指南基于循证医学证据,为临床提供了重要建议。未来与癌症登记数据库协作将是评估指南和建立新证据的关键。	Masato Nagino Satoshi Hirano Hideyuki Yoshitomi Taku Aoki Katsuhiko Uesaka Michiaki Unno Tomoki Ebata Masaru Konishi Keiji Sano Kazuaki Shimada Hiroaki Shimizu Ryota Higuchi Toshifumi Wakai Hiroyuki Isayama Takuji Okusaka Toshio Tsuyuguchi Yoshiki Hirooka Junji Furuse Hiroyuki Maguchi Kojiro Suzuki Hideya Yamazaki Hiroshi Kijima Akio Yanagisawa Masahiro Yoshida Yukihiro Yokoyama Takashi Mizuno Itaru Endo 杨翼飞(译) 仇毓东(译) 赵梦珂(译) 伏旭(译) 蔡正华(译) 毛凉(审校)	2021	中华消化外科杂志2021，20，4：	7
2	Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma显示文摘	Masatoshi Kudo Kazuho Imanaka Nobuyuki Chida Kohei Nakachi Won-Young Tak Tadatoshi Takayama Jung-Hwan Yoon Takeshi Hori Hiromitsu Kumada Norio Hayashi Shuichi Kaneko Hirohito Tsubouchi Dong Jin Suh Junji Furuse Takuji Okusaka Katsuaki Tanaka Osamu Matsui	2011	European Journal of Cancer2011，，14：	5
3	Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study显示文摘	Hedy L Kindler Tatsuya Ioka Dirk J Richel Jaafar Bennouna Richard Létourneau Takuji Okusaka Akihiro Funakoshi Junji Furuse Young Suk Park Shinichi Ohkawa Gregory M Springett Harpreet S Wasan Peter C Trask Paul Bycott Alejandro D Ricart Sinil Kim Eric Van	2011	Lancet Oncology2011，，3：	4
4	Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma显示文摘	Shunsuke Kondo Hidenori Ojima Hitoshi Tsuda Jun Hashimoto Chigusa Morizane Masafumi Ikeda Hideki Ueno Kenji Tamura Kazuaki Shimada Yae Kanai Takuji Okusaka	2013	International Journal of Clinical Oncology2013，，2：	2
5	Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma显示文摘	Takuji Okusaka Shuichi Okada Toshio Nakanishi Shigetoshi Fujiyama Yasuhiko Kubo	2004	Investigational New Drugs2004，，2：	2
6	Abdominal pain in patients with respectable pancreatic cancer with reference to clinicopathologic findings显示文摘	Okusaka T Okada S Ueno H	2001	Pancreas2001，22，3：	1
7	A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer显示文摘	MORIZANE C OKUSAKA T FURUSE J	2009	Cancer Chemother Pharmacol2009，63，2：	1
8	Transarterial chemo- therapy alone versus transarterial chemoembolization for hepato- cellular carcinoma:a randomized phase llI trial 显示文摘	Okusaka T Kasugai H Shioyama Y	2009	J Hepatol2009，51，6：	1
9	Randomized phase Ⅱ trial of Gemcitabine plus S - 1 combination therapy versus S - 1 in advanced biliary tract cancer显示文摘	Ikeda M Okusaka T Mizusawa J	2012	Annals of Oncolo- gy2012，23，11：	1
10	Tumor markers for pancreatic and biliary tract cancer 显示文摘	Takezako Y Okusaka T Ueno H	2004	Gan To Kagaku Ryoho2004，31，：	1
11	Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial ( JCOG 0805 ) 显示文摘	Morizane C Okusaka T Mizusawa J	2013	Cancer Sci2013，104，9：	1
12	S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study 显示文摘	FURUSE J OKUSAKA T BOKU N	2008	Cancer Chemother Pharmacol2008，62，5：	1
13	Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas显示文摘	Iwasa S Morizane C Okusaka T	2010	Jpn J Clin Oneol2010，40，4：	1
14	Early phase Ⅱ study of uracil-tegafur plus doxorubiein in patients with unreseetable advanced biliary tract cancer显示文摘	Furuse J Okusaka T Funakoshi A	2006	Jpn J Clin Oncol2006，36，9：	1
15	Abdominal pain in patients with resectable pancreatic cancer with reference to clinicopathologic findings显示文摘	Okusaka T Okada S Ueno H	2001	Pancreas2001，22，3：	1
16	Phase II study of combination chemotherapy with gemcitabine and cisplatin for patients with metastatic pancreatic cancer 显示文摘	Ueno H Okusaka T Ikeda M	2007	Jpn J Clin Oncol2007，37，：	1
17	Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features 显示文摘	Okusaka T Okada S Ueno H	2002	Cancer2002，95，9：	1
18	Serum levels of pro-gastrin releasing peptide for follow up of patients with small cell lung cancer显示文摘	Okusaka T Eguchi K Kasai T	1997	Clin Cancer Res1997，3，1：	1
19	Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection显示文摘	Ishii H Okada S Okusaka T	1998	Cancer1998，82，9：	1
20	Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma显示文摘	Takuji Okusaka Shuichi Okada Toshio Nakanishi Shigetoshi Fujiyama Yasuhiko Kubo	2004	Investigational New Drugs2004，，2：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示